BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2243140)

  • 21. The dualistic mechanisms of platelet adhesion to von Willebrand factor substrates.
    Santoro SA
    Exp Cell Res; 1987 Dec; 173(2):413-24. PubMed ID: 3500868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib.
    Fressinaud E; Baruch D; Girma JP; Sakariassen KS; Baumgartner HR; Meyer D
    J Lab Clin Med; 1988 Jul; 112(1):58-67. PubMed ID: 2455762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor in the vessel wall mediates platelet adherence.
    Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
    Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    Nicholson NS; Panzer-Knodle SG; Salyers AK; Taite BB; King LW; Miyano M; Gorczynski RJ; Williams MH; Zupec ME; Tjoeng FS
    J Pharmacol Exp Ther; 1991 Mar; 256(3):876-82. PubMed ID: 2005585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
    Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
    J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asialo-von Willebrand factor inhibits platelet adherence to human arterial subendothelium: discrepancy between ristocetin cofactor activity and primary hemostatic function.
    Lawrence JB; Gralnick HR
    Blood; 1987 Oct; 70(4):1084-9. PubMed ID: 3115333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces.
    Verkleij MW; Morton LF; Knight CG; de Groot PG; Barnes MJ; Sixma JJ
    Blood; 1998 May; 91(10):3808-16. PubMed ID: 9573018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A modified Arg-Asp-Val (RDV) peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV), a tetrapeptide derived from an alternatively spliced site in fibronectin, inhibits the binding of fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated platelets.
    Chen CS; Papayannopoulos IA; Timmons S; Chou SH; Thiagarajan P
    Biochim Biophys Acta; 1991 Oct; 1075(3):237-47. PubMed ID: 1720019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha.
    Bombeli T; Schwartz BR; Harlan JM
    J Exp Med; 1998 Feb; 187(3):329-39. PubMed ID: 9449713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI.
    Bonnefoy A; Harsfalvi J; Pfliegler G; Fauvel-Lafève F; Legrand C
    Thromb Haemost; 2001 Mar; 85(3):552-9. PubMed ID: 11307830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa.
    Parise LV; Helgerson SL; Steiner B; Nannizzi L; Phillips DR
    J Biol Chem; 1987 Sep; 262(26):12597-602. PubMed ID: 2957377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.
    de Groot PG; Ottenhof-Rovers M; van Mourik JA; Sixma JJ
    J Clin Invest; 1988 Jul; 82(1):65-73. PubMed ID: 2839553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.
    Haverstick DM; Cowan JF; Yamada KM; Santoro SA
    Blood; 1985 Oct; 66(4):946-52. PubMed ID: 3876125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation on extracellular matrix: effect of a recombinant GPIb-binding fragment of von Willebrand factor.
    Dardik R; Ruggeri ZM; Savion N; Gitel S; Martinowitz U; Chu V; Varon D
    Thromb Haemost; 1993 Sep; 70(3):522-6. PubMed ID: 8259558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
    Mondoro TH; Wall CD; White MM; Jennings LK
    Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains.
    Bayer AS; Sullam PM; Ramos M; Li C; Cheung AL; Yeaman MR
    Infect Immun; 1995 Sep; 63(9):3634-41. PubMed ID: 7642301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alphaIIbbeta3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium.
    Melis E; Bonnefoy A; Daenens K; Yamamoto H; Vermylen J; Hoylaerts MF
    J Thromb Haemost; 2004 Jun; 2(6):993-1002. PubMed ID: 15140136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. von Willebrand factor and platelet interactions with the vessel wall.
    Fressinaud E; Meyer D
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):333-40. PubMed ID: 1893064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.